Jan 10 (Reuters) - Akoya Biosciences Inc ( AKYA ):

* QUANTERIX TO ACQUIRE AKOYA BIOSCIENCES, CREATING THE FIRST

INTEGRATED SOLUTION FOR ULTRA-SENSITIVE DETECTION OF BLOOD- AND

TISSUE-BASED PROTEIN BIOMARKERS

* QUANTERIX TO ACQUIRE AKOYA BIOSCIENCES, CREATING THE FIRST

INTEGRATED SOLUTION FOR ULTRA-SENSITIVE DETECTION OF BLOOD- AND

TISSUE-BASED PROTEIN BIOMARKERS

* QUANTERIX CORP ( QTRX ) - TO ACQUIRE AKOYA BIOSCIENCES IN ALL-STOCK

TRANSACTION

* QUANTERIX CORP ( QTRX ) - AKOYA SHAREHOLDERS TO RECEIVE 0.318

SHARES OF

QUANTERIX STOCK PER SHARE

* QUANTERIX CORP ( QTRX ) - EXPECTED $40 MILLION ANNUAL COST

SYNERGIES BY

END OF 2026

* QUANTERIX CORP ( QTRX ) - SHAREHOLDERS TO OWN 70% OF COMBINED

COMPANY

Source text:

Further company coverage: